Halofuginone Suppresses Hepcidin by a Heparan Sulfate-dependent Mechanism to Treat Iron Disorders in Mice

By afschroeder • February 12, 2026

Leal S, Denardo A, Van Echten A, Jungnickel H, Nelson CB, Sandoval D, Salvador JA, Shin J, Chung A, Brush M, Bennett CP, Piermatteo A, Secrest P, Jung CL, Ganz T, Poli M, Gordts P. Halofuginone Suppresses Hepcidin by a Heparan Sulfate-dependent Mechanism to Treat Iron Disorders in Mice. Blood Adv. 2026 Feb 11:bloodadvances.2025017943. doi: 10.1182/bloodadvances.2025017943. Epub ahead of print. PMID: 41671472.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

The Epidemiology of Young-Onset Barrett’s Esophagus in the United States: A National Population-Based Study Using the TriNetX Database

Vasireddy AR, Chandar AK, Maravillas MA, Perez JA, Algarin Perneth SL, Kolb JM, Leggett CL, Katzka DA, Iyer PG, Gaddam S, Kamboj AK. The Epidemiology[...]

Activation of the impaired NAMPT/SIRT7/SOD2 axis restores alveolar progenitor renewal in idiopathic pulmonary fibrosis

Zhang X, Liu X, Qiao Y, Rabata A, Liu N, Yao C, Parimon T, Chen D, Hogaboam CM, Chen P, Stripp BR, Gardell SJ, Jiang[...]

Choice of cardioplegia influences metabolomics of human cardiac tissue

Tanosaki S, Zhang Y, Bedi K, Margulies K, Cox JE, Arany Z, Abel ED. Choice of cardioplegia influences metabolomics of human cardiac tissue. Proc Natl[...]